588 reports of this reaction
2.3% of all EPOETIN ALFA reports
#5 most reported adverse reaction
NAUSEA is the #5 most commonly reported adverse reaction for EPOETIN ALFA, manufactured by Amgen, Inc. There are 588 FDA adverse event reports linking EPOETIN ALFA to NAUSEA. This represents approximately 2.3% of all 25,704 adverse event reports for this drug.
Patients taking EPOETIN ALFA who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is a less commonly reported adverse event for EPOETIN ALFA, but still significant enough to appear in the safety profile.
In addition to nausea, the following adverse reactions have been reported for EPOETIN ALFA:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 588 FDA reports for EPOETIN ALFA. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 2.3% of all adverse event reports for EPOETIN ALFA, making it a notable side effect.
If you experience nausea while taking EPOETIN ALFA, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.